论文信息 - Defining the role of mass spectrometry in cancer diagnostics.

Defining the role of mass spectrometry in cancer diagnostics.

The prospect of uncovering the information contained in the human genome garnered such great promise that it attracted a synergistic blend of researchers from multiple disciplines. Notably, this group included molecular biologists, clinician-scientists, computational mathematicians, and industry

O John Semmes

[1] J. Yates. Mass spectral analysis in proteomics. , 2004, Annual review of biophysics and biomolecular structure.

[2] Virginia Espina,et al. Clinical proteomics: revolutionizing disease detection and patient tailoring therapy. , 2004, Journal of proteome research.

[3] R. Aebersold,et al. Mass spectrometry-based proteomics , 2003, Nature.

[4] P. Schellhammer,et al. Quantitation of serum prostate-specific membrane antigen by a novel protein biochip immunoassay discriminates benign from malignant prostate disease. , 2001, Cancer research.

[5] M S Pepe,et al. Phases of biomarker development for early detection of cancer. , 2001, Journal of the National Cancer Institute.

[6] M. Tyers,et al. From genomics to proteomics , 2003, Nature.

[7] S. Gygi,et al. Haptoglobin-alpha subunit as potential serum biomarker in ovarian cancer: identification and characterization using proteomic profiling and mass spectrometry. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[8] R. Bast,et al. Three Biomarkers Identified from Serum Proteomic Analysis for the Detection of Early Stage Ovarian Cancer , 2004, Cancer Research.

[9] McDonald Wh,et al. Shotgun proteomics: integrating technologies to answer biological questions. , 2003, Current opinion in molecular therapeutics.